title: [The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].
abstract: The impact of prognostic factors for survival was analyzed in a group of 337 patients with Hodgkin's disease. The analysis of survival of patients comprised a total of 13 indicators: histological types LP, NS, MC, LD, clinical stages I, II, III, IV, E lesions, symptomatology A, B, size of the mediastinal tumour (index), age at onset of disease and sex. Cumulative survival of 5, 10, and 20 years in the whole group is 83%, 80% and 72% resp. A first complete remission was achieved by 284 patients, cumulative survival without the disease is 79% after 5 and 73% after 10 years since completion of primary treatment. A significantly adverse effect on the prognosis of survival is exerted by symptomatology B, a large mediastinal tumour, advanced age, clinical stage IV and III. Most important are the first two factors mentioned. An adverse prognostic factor for survival without disease is male sex. The therapeutic protocol was repeatedly modified in the course of 25 years with regard to prognostic patient groups.
authors.affiliation: Pneumologická klinika 1. LF UK, Praha.
authors.forename: L
authors.initials: L
authors.lastname: Melínova
authors.forename: Z
authors.initials: Z
authors.lastname: Hermanská
authors.forename: J
authors.initials: J
authors.lastname: Halíková
authors.forename: Z
authors.initials: Z
authors.lastname: Dienstbier
authors.forename: B
authors.initials: B
authors.lastname: Vacková
authors.forename: J
authors.initials: J
authors.lastname: Zámecník
authors.forename: E
authors.initials: E
authors.lastname: Skala
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006689:Hodgkin Disease / Q000401:mortality*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008482:Mediastinum; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate
vernacular_title: Význam postizení mediastina a dalsích rizikových faktorů pro prezití nemocných s Hodgkinovou chorobou.